Dotmatics Resources for SLAS2023
Dotmatics provides comprehensive R&D scientific software solutions showcased at SLAS2023, including an overview of their platform, the Prism integration for enhanced data visualization and analysis, and specialized resources for biologics and small molecule discovery, with options to download content, speak with product experts, and request demos.
Content Showcase
Dotmatics Resources for SLAS2023
View some of our premium content to learn about the Dotmatics platform and other solutions from subject matter experts.
Table of contents
- What is Dotmatics?
- Prism by Dotmatics
- Biologics Discovery Resources
- Small Molecule Discovery Resources
- Speak with a Product Expert
- Get a Demo of Dotmatics at SLAS Europe
Download, watch and save some of the premium content we share at SLAS2023.
What is Dotmatics?
Dotmatics is the global leader in R&D scientific software that connects science, data, and decision-making. Combining a workflow and data platform with best-of-breed applications, we offer the first true end-to-end solutions for biology, chemistry, formulations, data management, flow cytometry, and more.
Download: Overview of Dotmatics
Prism by Dotmatics
Prism Integration: Templated Export of Dotmatics Data into Prism
Watch the Prism integration in action, so you can see first-hand how the connection would accelerate your research and expand your visualization and analysis capabilities.
Templated Export of Dotmatics Data into Prism
Press O for more options

Click for sound
3:57
Download our Prism Integration resources to uncover the features, benefits and answers to frequently asked questions about the integration.
Download: The Prism Integration Overview
Download: The Prism Integration FAQ
The GraphPad Prism Solution
Learn how you can achieve enhanced analysis and visualization for your scientific research with GraphPad Prism.
Download: The GraphPad Prism Solution
Biologics Discovery Resources
The Dotmatics Biology Solution provides end-to-end data management and analysis capabilities that fit into your established research and development workflow.
Download Overview: Biology Enterprise Solution
The pressure to innovate in biologics discovery is extraordinarily high. In our eBook, you will learn how to overcome this pressure with modern solutions to improve access to novel therapies.
Download eBook: Optimizing Biologics Discovery
Small Molecule Discovery Resources
With rising pressure to do more with less, companies need to adopt processes and technologies that will help them drive innovation while controlling costs.
Download Overview: Small Molecule Discovery Solution Overview
In this eBook, learn how to address common challenges in small molecule drug discovery so you can ensure data is trustworthy and traceable, improve productivity and collaboration, speed up research, and reduce technical debt and total cost of ownership.
Download eBook: Optimizing Small Molecule Discovery
Demo: Small Molecule Discovery in Dotmatics
Small Molecule Standard Demo Webinar
Press O for more options

Click for sound
32:58
Speak with a Product Expert
Request to speak with a subject matter expert so you can discover how a unified solution can address your specific needs.
Get a Demo of Dotmatics at SLAS Europe
First name
Last name
Phone
CountryUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe
Company
Message
Comments
Request a Demo
Request a Free Demo of Dotmatics
See how a unified platform can accelerate research and help address your specific challenges.
First name
Last name
Company
Phone
Job Title
CountryUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe
Message
Comments
Submit
Keep reading
Case Study\
Unlocking Novel Targets to Treat Neuroscience Diseases at Cerevel Therapeutics
Blog\
Waiting for a Rebound: Biotechs Refocus and Run Lean

Get Started
Speak with one of our product experts to see how Dotmatics can enhance your current practices.
